Liraglutide (Saxenda, Victoza): An older GLP-1 option, liraglutide requires daily injections and is approved for both weight loss and diabetes management
Improperly reconstituted tirzepatide, whether from mechanical denaturation (shaking), incorrect concentration (wrong water volume), or degradation (poor storage), delivers less active peptide than the label suggests
Pharmaceutical trials exclude pregnant and nursing participants for ethical reasons, leaving lactation-specific data sparse
Unfortunately, some users have experienced serious, debilitating, and life-changing side effects or complications from these drugs
Lifestyle Changes: A healthy diet, regular physical activity and sustainable lifestyle habits remain the foundation of long-term weight management